Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 135-OR
Author(s):  
WILLIAM T. CEFALU ◽  
TAMARA DARSOW ◽  
MATT PETERSEN ◽  
LIISA PALMER ◽  
ELLEN THIEL ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Treatment Persistence ◽  
Real World Setting

2220-PUB: Renal Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus in a Real-World Setting: The Renal-WECAN Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 2220-PUB
Author(s):  
JUAN J. GORGOJO-MARTINEZ ◽  
MANUEL A. GARGALLO-FERNANDEZ ◽  
ALBA GALDON ◽  
TERESA ANTÓN-BRAVO ◽  
MIGUEL BRITO-SANFIEL ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Sglt2 Inhibitor ◽  
Inhibitor Therapy ◽  
Renal Outcomes ◽  
Real World Setting

scholarly journals Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non‐insulin antidiabetic drugs in a real‐world setting

2019 ◽  
Vol 21 (6) ◽  
pp. 1373-1380 ◽  
Author(s):  
Silvia Canivell ◽  
Manel Mata‐Cases ◽  
Jordi Real ◽  
Josep Franch‐Nadal ◽  
Bogdan Vlacho ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Real World ◽  
Antidiabetic Drugs ◽  
Treatment Intensification ◽  
Real World Setting
Sign in / Sign up

Export Citation Format

Share Document